GHO Capital

GHO Capital Partners, established in 2014, is a London-based private equity firm specializing in healthcare investments. It focuses on buyouts and middle market companies within the healthcare sector, targeting outsourced services, pharmaceuticals, biotechnology, medical technology, and diagnostics. GHO Capital invests in European companies with enterprise values ranging from €100 million to €400 million, typically committing between €25 million to €125 million per investment. The firm aims to build market-leading businesses of strategic global value, leveraging its global capabilities and perspectives.

Chris Benson

Vice President

Brad Cain

Director

Alex Cox

Vice President

Holly Cromar

Senior Associate

Cédric Degryse

Vice President

Ken Eichmann

Partner

David Hall

Director

Youssef Hegazi

Senior Associate

Matthew Holdom

Senior Associate

Nico Iacuzzi

Principal

Claire Jaouen

Senior Associate

Charles Leong

Vice President

Alan MacKay

Managing Partner and Founder

Alessandra Macmillan

Senior Associate

Hendrik Michaelis

Associate

Michael I. Mortimer

Partner and Founder

Edward de Nor

Partner

Sabina Ouimet-Storrs

Principal

Andrea Ponti

Managing Partner and Founder

Manuela Rankine

Director of Sustainable Investing

Charles Ruprecht

Director

Robert Saltrick

Director

Leo Shui

Principal

Camilla Veroni

Associate

Alan MacKay

Managing Partner and Founder

23 past transactions

Avid Bioservices

Private Equity Round in 2024
Avid Bioservices is a contract development and manufacturing organization (CDMO) specializing in biopharmaceutical products. It offers a range of services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. The company focuses on quality and expertise, tailoring its services to meet the unique needs of its clients, primarily pharmaceutical and biotechnology companies. By outsourcing to Avid Bioservices, these companies can accelerate the development and manufacturing of their biologics, ultimately expediting the delivery of new therapies to patients.

Sapio Sciences

Acquisition in 2022
Sapio Sciences specializes in developing laboratory management and scientific data management software through its Exemplar Seamless Informatics Platform. This platform encompasses a Laboratory Information Management System (LIMS), Electronic Lab Notebooks (ELN), and enterprise data management tools, designed to streamline lab workflows, track experiments, and integrate various life science data. The web-based LIMS offers customizable workflows tailored for different research needs, including clinical and bioanalytical applications. The ELN enhances collaboration among scientists by allowing real-time experimentation and data tracking through an intuitive interface. Built on a no-code, AI-powered platform, Exemplar Seamless enables researchers to easily configure and visualize their data, thus improving overall lab efficiency. With a focus on accessibility and user-friendliness, Sapio Sciences provides a comprehensive solution for managing laboratory operations and scientific research.

Alcami

Acquisition in 2022
Alcami Corporation is a contract development and manufacturing organization (CDMO) based in Wilmington, North Carolina, specializing in services for the pharmaceutical and biotechnology sectors. The company provides a range of offerings, including sterile fill-finish development, oral solid dose development, formulation and analytical development, microbial identification, and stability storage. By focusing on small and mid-sized pharmaceutical and biotech companies, Alcami aims to deliver a streamlined, cost-effective approach to product commercialization, helping clients navigate the complexities of drug development and manufacturing.

Lykan BioScience

Private Equity Round in 2022
Lykan BioScience, LLC, founded in 2017 and based in Phoenix, Arizona, specializes in providing outsourced end-to-end production and logistics solutions tailored for pharmaceutical and biotech companies. The company offers a comprehensive range of services, including point-of-care, tech transfer, manufacturing, operations access, quality program management, operations management, and supply chain management. Additionally, Lykan BioScience focuses on contract development and manufacturing services specifically for cell-based therapies, supporting clients throughout the entire production process.

RoslinCT

Private Equity Round in 2022
RoslinCT is a UK-based Contract Development and Manufacturing Organisation (CDMO) that specializes in cell and gene therapy. The company offers a range of services tailored for organizations developing cell-based therapeutic products. Its expertise encompasses tissue procurement, cryopreservation studies, pre-clinical studies, and analytical development. By providing these services, RoslinCT enables its clients to create compliant, sustainable, and cost-effective therapies, supporting advancements in the field of regenerative medicine.

Biocare Medical

Private Equity Round in 2021
Biocare Medical, LLC specializes in developing and supplying automated immunohistochemistry (IHC) instrumentation and a comprehensive range of reagents for laboratory testing. The company is recognized as a leader in multiplex IHC tests, which enhance diagnostic confidence and streamline patient therapy processes. Biocare Medical's product offerings include primary antibodies, detection kits, chromogens, and advanced micro-polymer detection systems that provide superior specificity and sensitivity. Additionally, the company provides various ancillary products such as decalcification agents, blocking reagents, and technical support services. Its clientele encompasses clinical histology laboratories, pharmaceutical companies, contract research organizations, biotechnology firms, as well as academic and government institutions. Biocare Medical operates from its headquarters in Pacheco, California, and has established a global distribution network to effectively market its innovative diagnostic solutions. Founded in 1997, the company continues to expand its portfolio to meet the evolving demands of cancer and infectious disease diagnostics.

Genesis Research

Acquisition in 2021
Genesis Research is a global life sciences research and consulting company that offers comprehensive evidence development, management, and communication services. The firm specializes in value evidence strategy, economic modeling, and data analytics, providing clients with the tools necessary to address complex challenges in the life sciences sector. Additionally, Genesis Research features unique offerings such as rapid response analytics, outcomes simulation, and the EVID AI literature search platform, along with collaborative payer data services. By focusing on delivering timely and high-quality solutions, Genesis Research supports life sciences companies in demonstrating product value effectively.

Sanner Group

Private Equity Round in 2021
Sanner Group is a manufacturer specializing in primary plastic packaging systems. The company focuses on producing a wide range of products, including effervescent tablets, test strips, desiccant sachets, capsules, caps, plastic tubes, closures, glass bottles, and aluminum tubes. Sanner Group aims to enhance efficiency in material use while minimizing energy consumption and carbon dioxide emissions. Their offerings are tailored to meet specific needs in various sectors such as medical technology, diagnostics, pharmaceuticals, and consumer healthcare.

ClearView Healthcare Partners

Acquisition in 2021
ClearView Healthcare Partners LLC is a global strategy consulting firm that specializes in providing strategic consulting services to life science companies and investors. Founded in 2007 and based in Newton, Massachusetts, the firm focuses on the pharmaceutical, biotechnology, medical device, and diagnostics sectors. ClearView supports clients through various strategic engagements, including indication prioritization, long-term therapeutic area strategy, due diligence, and clinical development strategy. In addition to new product planning and strategic marketing, the firm offers consulting services for business development and private equity investors, as well as strategic market research. Serving a diverse clientele that ranges from emerging biotechnology firms to established global pharmaceutical companies, ClearView combines industry knowledge and scientific expertise to deliver practical solutions to complex challenges faced by its clients.

Velocity Clinical Research

Acquisition in 2021
Velocity Clinical Research specializes in delivering clinical trial services and data to biopharmaceutical and contract research organizations. The company focuses on facilitating the successful execution of clinical studies by offering comprehensive support in areas such as feasibility assessment, contracting, patient recruitment, study management, and billing. By ensuring a centralized point of contact for these services, Velocity aids its clients in upholding high standards of care while expediting the development and deployment of innovative medical treatments across various therapeutic areas. The company is dedicated to connecting new medications to the patients who need them promptly and effectively.

Envision Pharma Group

Acquisition in 2020
Envision Pharma Group is a scientific communications and technology company that specializes in serving the life sciences sector, including pharmaceutical, biotechnology, and medical device industries. The company collaborates with clients, authors, and the medical publishing community to create and implement evidence-based communication programs in a transparent and compliant manner. Envision provides a comprehensive suite of services that includes artificial intelligence and natural language processing, integrated strategic consulting, scientific communications, health economics and outcomes research, market access, and data analytics. Its software solutions facilitate the development of global medical strategies and support cross-functional teams in managing scientific communications. This enables clients to effectively connect with their audiences and ensures compliance with regulatory standards throughout the product life cycle.

X-Chem

Acquisition in 2020
X-Chem, Inc. is a biotechnology company based in Waltham, Massachusetts, founded in 2009. The company specializes in discovering small molecule leads for high-value therapeutic targets, utilizing its innovative DNA-Encoded Library (DEL)-based discovery services. X-Chem's approach involves the iterative combinatorial synthesis of small molecules, which are linked to DNA tags that document their synthetic history. This unique methodology enables the efficient generation of novel therapeutics, positioning X-Chem as a key player in the biotechnology sector.

Fairjourney Biologics

Venture Round in 2020
Fairjourney Biologics SA is a contract research organization based in Porto, Portugal, founded in 2012. The company specializes in providing comprehensive antibody discovery services, including therapeutics, diagnostics, imaging tools, and research tools such as Llama VHHS antibodies, rodent antibodies, rabbit antibodies, human antibodies, and chicken antibodies. Fairjourney Biologics also offers antibody engineering services like affinity maturation, humanization, and sequence optimization, along with antibody production services that involve recombinant expression of antibodies and their fragments. With over a decade of experience, the company leverages advanced technologies and a team of experienced researchers to deliver high-quality, reliable antibodies tailored to meet the unique needs of its diverse partners, which include venture capital firms, virtual companies, spin-offs, biotech companies, and large pharmaceutical corporations.

Ardena

Acquisition in 2020
Ardena Group is a provider of pharmaceutical development services, specializing in early-stage drug development and manufacturing for small to mid-sized biopharma companies. The company operates as a contract partner, offering a range of services that include pre-clinical and clinical drug development, drug research, manufacturing, and bio-analysis. By guiding clients through the drug discovery process, Ardena helps to create effective and compliant pharmaceutical products for clinical trials, supporting the advancement of innovative therapies in the biopharmaceutical sector.

Sterling Pharma Solutions

Acquisition in 2019
Sterling Pharma Solutions is a provider of development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) tailored to the pharmaceutical industry. The company specializes in outsourced contract manufacturing, offering expertise in API development, medical engineering, project management, and supply chain management. By delivering contract good manufacturing practices (GMP) services, Sterling Pharma Solutions enables its clients to concentrate on their projects throughout the entire product lifecycle, ensuring high-quality support and efficiency in their operations.

BioAgilytix Labs

Venture Round in 2019
BioAgilytix Labs, LLC is a bioanalytical laboratory that specializes in large-molecule bioanalysis for preclinical and clinical studies. Founded in 2008 and headquartered in Durham, North Carolina, with additional locations in Hamburg, Germany, and Boston, Massachusetts, the company provides a range of services including biomarker development, immunogenicity assessments, pharmacokinetics, and cell-based assays. BioAgilytix serves various industries, including pharmaceuticals, biotechnology, animal health, cosmetics, and agricultural biotechnology. The company focuses on supporting drug development across multiple therapeutic areas, including gene therapy, CAR T-cell therapy, biosimilars, and immuno-oncology. By employing a team of highly experienced scientists, BioAgilytix aims to deliver high-quality bioanalytical services that meet regulatory standards and support the success of its partners in their scientific endeavors.

Validant

Acquisition in 2018
They have assembled a network of subject matter experts that is not only expansive, but also versatile. This gives their clients access to a wide range of experts that fit their initiatives and are deployable at a moment’s notice.

Linimed

Acquisition in 2018
Linimed GmbH, founded in 1994 and based in Jena, Germany, specializes in home nursing and outpatient care services, focusing on patients with severe health conditions such as neurological and neuromuscular diseases, obstructive respiratory diseases, and other complex medical needs. The company operates a network of 52 community care centers across Germany, providing 24/7 intensive care and support services to approximately 250 patients. With a workforce of around 930 employees, Linimed is recognized for its high-quality, efficient care delivery model that aims to reduce costs for the healthcare system while improving patient outcomes. The organization is committed to enhancing the quality of life for individuals requiring intensive care and assisted living support.

Alcaliber

Acquisition in 2018
Alcaliber S.A., founded in 1973 and headquartered in Madrid, Spain, specializes in the manufacture of active pharmaceutical ingredients (APIs), narcotic raw materials (NRMs), and cannabis products. The company serves the global pharmaceutical industry and has established a strong reputation for quality, backed by over 45 years of experience in a highly regulated market. Alcaliber manages the entire production process, including autonomous poppy cultivation, ensuring clients receive the opiates needed for medical treatments. Its subsidiary, Linneo Health, complements its operations, contributing to Alcaliber's position as a leading supplier in the niche sector of narcotic materials. The company's commitment to best-in-class industrial practices has enabled stable and sustainable growth.

Caprion

Acquisition in 2016
Caprion Proteomics, Inc. is a clinical research organization based in Montreal, Canada, specializing in proteomics and immune monitoring services for the pharmaceutical and biotechnology sectors. The company provides two primary platforms: ImmuneCarta, which utilizes multiparametric flow cytometry for in-depth analyses of immune responses, and ProteoCarta, which employs gel-free and label-free mass spectrometry to compare protein levels across biological samples for biomarker discovery. Caprion offers a diverse range of services, including cell sorting, functional profiling, biomarker discovery, and various assays, addressing multiple disease areas such as autoimmune, cardiovascular, metabolic, neurology, and infectious diseases. Established in 2000, Caprion is dedicated to advancing precision medicine in drug development through strategic partnerships, including one with Viroclinics-DDL. The company rebranded from Caprion Proteomics GP to its current name in July 2007 and operates as a subsidiary of HistoGeneX NV.

VISUfarma

Acquisition in 2016
VISUfarma is a pan-European ophthalmic specialty pharmaceutical company focused on enhancing eye health across Europe. The company develops, markets, and distributes a diverse range of ophthalmology products and devices, which support healthcare providers, including physicians, hospitals, and medical centers, in delivering high-quality eye care to patients. By emphasizing global innovation, VISUfarma aims to advance the standards of eye health treatment and improve patient outcomes throughout the region.

Quotient Sciences

Acquisition in 2015
Quotient Sciences is a provider of contract manufacturing services focused on the pharmaceutical sector. The company specializes in formulation development, clinical pharmacology, and both clinical and commercial manufacturing. By offering these services, Quotient Sciences enables pharmaceutical companies to accelerate the development of new drugs through outsourcing various operational processes. This approach allows clients to enhance their efficiency and focus on core competencies while leveraging Quotient Sciences' expertise in drug development.

DNA Diagnostics Center

Acquisition in 2015
DNA Diagnostics Center, Inc., established in 1995 and located in Fairfield, Ohio, specializes in genetic testing services. The company provides a range of DNA tests, including paternity and family relationship assessments, as well as fertility, lifestyle, veterinary, and forensic testing. Utilizing automated precision instrumentation, DNA Diagnostics Center ensures accurate and efficient results, catering to consumers, government agencies, legal professionals, and healthcare practitioners. The service emphasizes privacy and affordability, enabling clients to obtain timely answers to their genetic inquiries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.